S-100 (ADWATIS SA) has been shortlisted as a finalist in Excipient category in the CPhI Pharma Awards.

S-100 (ADWATIS SA) has been shortlisted as a finalist in Excipient category in the CPhI Pharma Awards.

2018.09.27.

Following the honor that S-100 won the best prize at COSMETIC 360 in October 2017, it has been nominated as a finalist in the Excipients category at the International Pharmaceutical Exhibition "CPhI Pharma 2018" to be held at the Eurostars Madrid Tower in Spain in October 2018.

It was evaluated that S-100 has high technology and unique characteristics which can be applied to many medical applications such as wound healing, thermal wounds (burns), atopic dermatitis and other skin disorders. In addition, research results of S - 100 were evaluated in its genuine and unique mechanisms of action.

https://awards.cphi.com/

180927_CPhI_Pharma_finalist.jpgCPhI 2018 ADWATIS finaist.jpeg